BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36635201)

  • 1. Towards artificial intelligence-based automated treatment planning in clinical practice: A prospective study of the first clinical experiences in high-dose-rate prostate brachytherapy.
    Barten DLJ; Pieters BR; Bouter A; van der Meer MC; Maree SC; Hinnen KA; Westerveld H; Bosman PAN; Alderliesten T; van Wieringen N; Bel A
    Brachytherapy; 2023; 22(2):279-289. PubMed ID: 36635201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bi-objective treatment planning for high-dose-rate prostate brachytherapy-A retrospective observer study.
    Maree SC; Luong NH; Kooreman ES; van Wieringen N; Bel A; Hinnen KA; Westerveld H; Pieters BR; Bosman PAN; Alderliesten T
    Brachytherapy; 2019; 18(3):396-403. PubMed ID: 30718176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic bi-objective parameter tuning for inverse planning of high-dose-rate prostate brachytherapy.
    Maree SC; Bosman PAN; van Wieringen N; Niatsetski Y; Pieters BR; Bel A; Alderliesten T
    Phys Med Biol; 2020 Apr; 65(7):075009. PubMed ID: 32028270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keeping your best options open with AI-based treatment planning in prostate and cervix brachytherapy.
    Dickhoff LRM; Scholman RJ; Barten DLJ; Kerkhof EM; Roorda JJ; Velema LA; Stalpers LJA; Pieters BR; Bosman PAN; Alderliesten T
    Brachytherapy; 2024; 23(2):188-198. PubMed ID: 38296658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPU-accelerated bi-objective treatment planning for prostate high-dose-rate brachytherapy.
    Bouter A; Alderliesten T; Pieters BR; Bel A; Niatsetski Y; Bosman PAN
    Med Phys; 2019 Sep; 46(9):3776-3787. PubMed ID: 31236948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the impact of real-time multicriteria optimizers integrated with interactive plan navigation tools for HDR brachytherapy.
    Bélanger C; Poulin É; Cui S; Vigneault É; Martin AG; Foster W; Després P; Cunha JAM; Beaulieu L
    Brachytherapy; 2020; 19(5):607-617. PubMed ID: 32713779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GPU-based multi-criteria optimization algorithm for HDR brachytherapy.
    Bélanger C; Cui S; Ma Y; Després P; Adam M Cunha J; Beaulieu L
    Phys Med Biol; 2019 May; 64(10):105005. PubMed ID: 30970341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-objective optimization of catheter positions for high-dose-rate prostate brachytherapy.
    van der Meer MC; Bosman PAN; Niatsetski Y; Alderliesten T; van Wieringen N; Pieters BR; Bel A
    Med Phys; 2020 Dec; 47(12):6077-6086. PubMed ID: 33000874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the role of constrained CVT and CVT in HIPO inverse planning for HDR brachytherapy of prostate cancer.
    Sachpazidis I; Hense J; Mavroidis P; Gainey M; Baltas D
    Med Phys; 2019 Jul; 46(7):2955-2968. PubMed ID: 31055834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-observer evaluation of a GPU-based multicriteria optimization algorithm combined with plan navigation tools for HDR brachytherapy.
    Bélanger C; Poulin É; Aubin S; Vigneault É; Martin AG; Foster W; Beaulieu L
    Brachytherapy; 2022; 21(4):551-560. PubMed ID: 35585019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
    Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
    Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate.
    Lachance B; Béliveau-Nadeau D; Lessard E; Chrétien M; Hsu IC; Pouliot J; Beaulieu L; Vigneault E
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):86-100. PubMed ID: 12182978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy.
    Edmundson GK; Yan D; Martinez AA
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1257-63. PubMed ID: 7493850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IPIP: A new approach to inverse planning for HDR brachytherapy by directly optimizing dosimetric indices.
    Siauw T; Cunha A; Atamtürk A; Hsu IC; Pouliot J; Goldberg K
    Med Phys; 2011 Jul; 38(7):4045-51. PubMed ID: 21859003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous needle catheter selection and dwell time optimization for preplanning of high-dose-rate brachytherapy of prostate cancer.
    Wang C; Gonzalez Y; Shen C; Hrycushko B; Jia X
    Phys Med Biol; 2021 Mar; 66(5):055028. PubMed ID: 33264753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of automated post-adjustments of HDR prostate brachytherapy treatment plans by quantitative measures and oncologist observer study.
    Dohlmar F; Morén B; Sandborg M; Smedby Ö; Valdman A; Larsson T; Carlsson Tedgren Å
    Brachytherapy; 2023; 22(3):407-415. PubMed ID: 36739222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter position prediction using deep-learning-based multi-atlas registration for high-dose rate prostate brachytherapy.
    Lei Y; Wang T; Fu Y; Roper J; Jani AB; Liu T; Patel P; Yang X
    Med Phys; 2021 Nov; 48(11):7261-7270. PubMed ID: 34480801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gEUD-based inverse planning technique for HDR prostate brachytherapy: feasibility study.
    Giantsoudi D; Baltas D; Karabis A; Mavroidis P; Zamboglou N; Tselis N; Shi C; Papanikolaou N
    Med Phys; 2013 Apr; 40(4):041704. PubMed ID: 23556874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy.
    Smith RL; Panettieri V; Lancaster C; Mason N; Franich RD; Millar JL
    Australas Phys Eng Sci Med; 2015 Mar; 38(1):55-61. PubMed ID: 25481387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.